Transaction · 0001437749-26-032421

Degnan Chris

Degnan Chris, CFO, reported a transaction classified as exercise at UroGen Pharma Ltd. involving 4483.000000 shares. Reported holdings after the transaction were 6763.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MCFO
URGNUroGen Pharma Ltd.
Filing timeOct 09
Trade dateOct 08, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position tradedUnavailableCalculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$36.97
Pre-filing
1mo ago +18.5%1w ago +9.7%1d ago +10.1%
Returns since
7d30d90d180d1y

URGN price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
URGN since 2026-10-09Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0001437749-26-032421
Ordinary Shares
Transaction date
Oct 08, 2026
Filed Oct 09, 2026, 04:57 PM · 1d delay
Shares
4.48k sh
Price unknown
Estimated value
—
Computed from shares × price
Holdings after
6.76k sh
Direct

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Large Holdings Increase
+2score
Filing-only score

+2

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Financial Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.

  2. F2

    Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.

  3. F3

    The reporting person was granted RSUs on October 8, 2024 representing 13,450 ordinary shares. The RSUs will vest in three equal annual installments from October 8, 2025.

Original filing · 0001437749-26-032421
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

URGN